Biogen Inc.
BIIB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $466,500 | $634,800 | $240,500 | $266,700 |
| Dep. & Amort. | $202,200 | $194,300 | $183,200 | $184,000 |
| Deferred Tax | $253,800 | -$31,300 | -$27,800 | -$58,400 |
| Stock-Based Comp. | $75,300 | $74,900 | $81,000 | $75,100 |
| Change in WC | $174,200 | -$789,600 | -$333,500 | $28,300 |
| Other Non-Cash | $100,500 | $77,800 | $115,900 | $265,200 |
| Operating Cash Flow | $1,272,500 | $160,900 | $259,300 | $760,900 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$51,500 | -$26,600 | -$47,100 | -$66,300 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$91,000 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $56,600 | $0 | $0 | -$40,600 |
| Other Inv. Act. | $50,800 | -$30,400 | -$200 | $88,300 |
| Investing Cash Flow | -$35,100 | -$57,000 | -$47,300 | -$18,600 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$300 | -$16,600 | $0 | $0 |
| Stock Issued | $5,200 | $6,100 | -$24,300 | $3,500 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$135,100 | -$1,200 | $1,300 | $4,400 |
| Financing Cash Flow | -$130,200 | -$11,700 | -$23,000 | $7,900 |
| Forex Effect | -$3,200 | $68,300 | $34,300 | -$74,400 |
| Net Chg. in Cash | $1,104,000 | $160,500 | $223,300 | $675,800 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,758,800 | $2,598,300 | $2,375,000 | $1,699,200 |
| End Cash | $3,862,800 | $2,758,800 | $2,598,300 | $2,375,000 |
| Free Cash Flow | $1,226,300 | $144,300 | $212,200 | $694,600 |